Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8,846 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells.
Yo Y, Morishita R, Nakamura S, Tomita N, Yamamoto K, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Yo Y, et al. Kidney Int. 1998 Oct;54(4):1128-38. doi: 10.1046/j.1523-1755.1998.00092.x. Kidney Int. 1998. PMID: 9767528
HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y. Nakabayashi M, et al. Diabetologia. 2003 Jan;46(1):115-23. doi: 10.1007/s00125-002-0954-y. Epub 2002 Dec 6. Diabetologia. 2003. PMID: 12637990
Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft.
Matsumoto K, Konno H, Tanaka T, Baba M, Kanai T, Kamiya K, Ohba K, Nakamura S. Matsumoto K, et al. Jpn J Cancer Res. 2000 Jul;91(7):748-52. doi: 10.1111/j.1349-7006.2000.tb01008.x. Jpn J Cancer Res. 2000. PMID: 10920283 Free PMC article.
Human chorionic gonadotropin-alpha gene is transcriptionally activated by epidermal growth factor through cAMP response element in trophoblast cells.
Matsumoto K, Yamamoto T, Kurachi H, Nishio Y, Takeda T, Homma H, Morishige K, Miyake A, Murata Y. Matsumoto K, et al. J Biol Chem. 1998 Apr 3;273(14):7800-6. doi: 10.1074/jbc.273.14.7800. J Biol Chem. 1998. PMID: 9525871
Impaired endothelial dysfunction in diabetes mellitus rats was restored by oral administration of prostaglandin I2 analogue.
Matsumoto K, Morishita R, Tomita N, Moriguchi A, Yamasaki K, Aoki M, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Matsumoto K, et al. J Endocrinol. 2002 Oct;175(1):217-23. doi: 10.1677/joe.0.1750217. J Endocrinol. 2002. PMID: 12379506
Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactions.
Matsumoto K, Date K, Ohmichi H, Nakamura T. Matsumoto K, et al. Cancer Chemother Pharmacol. 1996;38 Suppl:S42-7. doi: 10.1007/s002800051037. Cancer Chemother Pharmacol. 1996. PMID: 8765416 Review.
Acquisition of invasive phenotype in gallbladder cancer cells via mutual interaction of stromal fibroblasts and cancer cells as mediated by hepatocyte growth factor.
Matsumoto K, Date K, Shimura H, Nakamura T. Matsumoto K, et al. Jpn J Cancer Res. 1996 Jul;87(7):702-10. doi: 10.1111/j.1349-7006.1996.tb00281.x. Jpn J Cancer Res. 1996. PMID: 8698619 Free PMC article.
Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor.
Morishita R, Higaki J, Hayashi SI, Yo Y, Aoki M, Nakamura S, Moriguchi A, Matsushita H, Matsumoto K, Nakamura T, Ogihara T. Morishita R, et al. Diabetologia. 1997 Sep;40(9):1053-61. doi: 10.1007/s001250050787. Diabetologia. 1997. PMID: 9300242
8,846 results
Jump to page
Feedback